symbol,price,beta,volAvg,mktCap,lastDiv,range,changes,companyName,currency,cik,isin,cusip,exchange,exchangeShortName,industry,website,description,ceo,sector,country,fullTimeEmployees,phone,address,city,state,zip,dcfDiff,dcf,image,ipoDate,defaultImage,isEtf,isActivelyTrading,isAdr,isFund
ENZN,0.1383,0.424472,7714,10263879,5.38,0.12-0.29,0.0118,"Enzon Pharmaceuticals, Inc.",USD,0000727510,US2939041081,293904108,Other OTC,PNK,Biotechnology,https://www.enzon.com,"Enzon Pharmaceuticals, Inc., together with its subsidiaries, engages in marketing drug products. The company's marketed drug product is PegIntron. It also has a marketing agreement relating to Vicineum drug. The company was founded in 1981 and is headquartered in Cranford, New Jersey.",Mr. Richard L. Feinstein,Healthcare,US,,732 980 4500,20 Commerce Drive,Cranford,NJ,07016,,0,https://financialmodelingprep.com/image-stock/ENZN.png,1984-02-15,False,False,True,False,False
